Is HHS or HON more undervalued in 2026?

CirclFi compares Harte Hanks, Inc. (HHS) and Honeywell International Inc. (HON) using 13 institutional-grade valuation models. HHS has a Quality of Company score of 6.0/10 while HON scores 8.6/10.

Which is a better buy — HHS or HON?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do HHS and HON valuations compare?

HHS at $2.58 and HON at $233.00 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

HHS vs HON Valuation Comparison 2026 — Intrinsic Value Analysis

HHS

Conglomerates

Harte Hanks, Inc.

Quality

6.0

out of 10

Value Trap

SAFE

Price

$2.58

Last close

Models

11/13

Active

HON

Conglomerates

Honeywell International Inc.

Quality

8.6

out of 10

Value Trap

SAFE

Price

$233.00

Last close

Models

13/13

Active

Model-by-Model Comparison

Model	Type	HHS Fair Value	HHS Upside	HON Fair Value	HON Upside
Bayesian DCF	Intrinsic	$10.97	+325.4%	$55.09	-76.4%
Earnings Power Value	Intrinsic	$4.57	+77.1%	$62.59	-73.1%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for HHS vs HON — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

HHS vs HON — Which Stock Is More Undervalued?

HON scores higher with a 8.6/10 quality rating vs HHS's 6.0/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Harte Hanks, Inc. (HHS) and Honeywell International Inc. (HON) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

HHS currently trades at $2.58 with a QOC of 6.0/10, while HON trades at $233.00 with a QOC of 8.6/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).